Internal Server Error

Specie Bio - About the company

Specie Bio is a funded company based in United States, founded in 2022 by Fergus Chan. It operates as a Digital platform to search and get access to samples and data. The company has 102 active competitors, including 14 funded and 7 that have exited. Its top competitors include companies like ArcaScience, Biorelate and ScienceIO.

Company Details

Digital platform to search and get access to samples and data. It offers BioExchange platform that enables users to find and access samples and data across an aggregated inventory from network of providers including hospitals, research institutes, medical centers and biobanks.
Key Metrics
Founded Year
2022
Location
Stage
Funding Raised
Ranked
Employee Count
7 as on Aug 31, 2026
Similar Companies
Sign up to download Specie Bio's company profile

Specie Bio's funding and investors

Specie Bio is a funded company. Specie Bio has 1 institutional investor.

Specie Bio's founders and board of directors

Founder? Claim Profile
The founders of Specie Bio is Fergus Chan. Fergus Chan is the CEO of Specie Bio.
Here are the details of Specie Bio's key team members:

Specie Bio's employee count trend

Specie Bio has 7 employees as of Aug 26. Here is Specie Bio's employee count trend over the years:
Employee count trend for Specie Bio
lockUncover Specie Bio's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Specie Bio's Competitors and alternates

Top competitors of Specie Bio include ArcaScience, Biorelate and ScienceIO. Here is the list of Top 10 competitors of Specie Bio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for ArcaScience
ArcaScience
2018, Paris (France), Seed
Developer of AI models for patient-centric insights in drug development
$7M
51/100
2nd
Logo for Biorelate
Biorelate
2014, Manchester (United Kingdom), Series A
Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction
$8.74M
47/100
3rd
Logo for ScienceIO
ScienceIO
2020, Boston (United States), Acquired
Provider of AI solutions transforming medical text into enriched healthcare data
$8M
46/100
4th
Logo for Kudos
Kudos
2013, Oxford (United Kingdom), Series A
Provider of research communication and showcase services. It helps researchers effectively communicate their work to a broader audience. The company offers tools and resources to enhance research visibility and impact. Services include creating engaging narratives around research findings and facilitating their dissemination across various platforms. This improves the reach and understanding of scientific discoveries.
$2.5M
45/100
5th
Logo for Longenesis
Longenesis
2017, Riga (Latvia), Seed
Digital platform for healthcare research and patient engagement
$1.19M
43/100
6th
Logo for Citelighter
Citelighter
2011, New York City (United States), Acquired
Digital writing solution for K-20 students
$6.58M
42/100
7th
Logo for Animares
Animares
1997, Bonn (Germany), Unfunded
Developer of 3D medical animations and augmented, mixed, virtual reality
-
-
42/100
8th
Logo for Protocols.io
Protocols.io
2012, Berkeley (United States), Seed
Life science protocol repository
$500K
41/100
9th
Logo for Pharmacodia
Pharmacodia
2013, Beijing (China), Series B
Online database solutions for pharmaceutical R&D
$14.5M
40/100
10th
Logo for Collaborative Drug Discovery
Collaborative Drug Discovery
2004, Burlingame (United States), Series A
Biological and chemical database to manage private and external data
-
39/100
64th
Logo for Specie Bio
Specie Bio
2022, United States, Funding Raised
Digital platform to search and get access to samples and data
-
-
17/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Specie Bio's competitors? Click here to see the top ones

Specie Bio's Investments and acquisitions

Specie Bio has made no investments or acquisitions yet.

Reports related to Specie Bio

Here is the latest report on Specie Bio's sector:

FAQs about Specie Bio

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford